Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies.
Ndlovu B. et al, (2025), PLoS pathogens, 21
Autovaccination revisited: potential to boost antiviral immunity and facilitate HIV-1 cure/remission in children.
Parker HR. et al, (2025), Current opinion in HIV and AIDS
Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.
Bengu N. et al, (2025), Nature medicine
Long-term non-progression in children living with HIV: estimates from international cohort data.
Jackson C. et al, (2025), AIDS (London, England)
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.
Amodio D. et al, (2025), Vaccine, 43
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium.
Kuhn L. et al, (2024), The lancet. HIV, 11, e700 - e710
Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries.
Morrocchi E. et al, (2024), Scientific reports, 14
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission
Bengu N. et al, (2024), Nature Medicine, 30, 2796 - 2804
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity
Liu C. et al, (2024), Cell Reports Medicine, 5, 101553 - 101553
Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population
Zacharopoulou P. et al, (2024), Frontiers in Immunology, 15
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile.
Nguyen AN. et al, (2023), Pediatric research, 94, 1667 - 1674
Impact of early antiretroviral therapy, early life immunity and immune sex differences on HIV disease and posttreatment control in children.
Herbert NG. and Goulder PJR., (2023), Current opinion in HIV and AIDS, 18, 229 - 236
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members
Jay C. et al, (2023), Frontiers in Immunology, 14
Hepatitis B Virus Prevalence and Mother-to-Child Transmission Risk in an HIV Early Intervention Cohort in KwaZulu-Natal, South Africa
Millar J. et al, (2023), Open Forum Infectious Diseases, 10
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Johnson SA. et al, (2023), Clinical and Experimental Immunology, 212, 249 - 261
Slow progression of pediatric HIV associates with early CD8+ T cell PD-1 expression and a stem-like phenotype
Vieira V. et al, (2023), JCI Insight, 8
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus
Fidler S. et al, (2023), Clinical Infectious Diseases, 76, 201 - 209
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
Huo J. et al, (2023), Cell Reports, 42, 111903 - 111903
Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents.
Jay C. et al, (2023), Frontiers in immunology, 14